Roei Mazor, MD, PhD, Assuta Medical Center, Tel Aviv, Israel, shares some insights into Langerhans cell histiocytosis (LCH) and explains how different subtypes of histiocytosis differ from one another by various factors including the driver oncogene, the clinical presentation, and by the capacity to diverge and to generate a polyclonal phenotype. The different treatment strategies for LCH and malignant histiocytosis are described. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
Watch video Types of histiocytosis and their treatment strategies online without registration, duration hours minute second in high quality. This video was added by user VJHemOnc – Video Journal of Hematology & HemOnc 21 July 2022, don't forget to share it with your friends and acquaintances, it has been viewed on our site 1,552 once and liked it 14 people.